Office of the Attorney General Robert E. Cooper, Jr. Department of Commerce and Insurance Commissioner Leslie Shechter Newman NEWS RELEASE

First Page		Document Content
Date: 2011-07-20 17:28:29 Clinical research Dow Jones Industrial Average Merck & Co. Readington New Jersey Schering-Plough Rofecoxib Food and Drug Administration Consumer protection Pharmaceutical industry Pharmaceutical sciences Pharmacology Merck		Office of the Attorney General Robert E. Cooper, Jr. Department of Commerce and Insurance Commissioner Leslie Shechter Newman NEWS RELEASE Add to Reading List Source URL: www.tn.gov Download Document from Source Website File Size: 27,90 KB Share Document on Facebook

	DEVELOPMENT OF PHARMACEUTICAL PRODUCTS UTILIZING EXTRUSION TECHNOLOGIES Graciela Terife Senior Scientist, Product Value Enhancement Merck & Co., Summit, NJ DocID: 1nXt9 - View Document
	Title: font: times; size: 18 point; style: plain; justified: center; capitalization: first word and Names only THE CHALLENGE OF DEVELOPING AN MMRVVV COMBINATION VACCINE Alan R. Shaw, PhD DocID: 1gGkP - View Document
	Your contact News Release Gangolf Schrimpf DocID: 1aWSz - View Document
	TRUSOPT Ped data PAR DocID: 1aNXe - View Document
	CNODES: A Canadian Initiative Samy Suissa Lady Davis Institute, Jewish General Hospital McGill University Montreal, Canada DocID: 1aAtH - View Document